Back to Article List

Use of ingredients in infant formula for special medical purposes

Taiwan

Sep 30, 2022

The Taiwan Food and Drug Administration (TFDA) consulted on the amendment to the use restriction of 2′-fucosyllactose (2′-FL) produced by genetically modified Escherichia coli strain K-12 DH1 MDO MAP1001d (hereinafter referred to as “E. coli K-12 MAP1001d”) and genetically modified Escherichia coli strain BL21 (DE3) #1540 (hereinafter referred to as “E. coli BL21 (DE3) #1540”).

 

For further information (in Chinese), click on the Link

Share:

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox

®